Layer3.news

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqqypukfw5y7he3mzvs4jfkdade8nhvcm2nzan44hrnxn22d86lecqp0g8t3

LPL ATTRACTS $700M TEXAS TEAM FROM WEDBUSH SECURITIES

https://media.zenfs.com/en/wealth_management_474/d904e9fba01357a0561d2f85c63f3a62

✍️ A Houston-based team, Skyward Financial, managing $700 million in client assets, joins LPL Financial from Wedbush Securities, citing the need for better technology and scalability.

👉 Skyward Financial joins LPL Financial from Wedbush Securities 👉 The team manages $700 million in client assets 👉 The move is driven by the need for better technology and scalability 👉 LPL Financial has acquired Commonwealth Financial Network 👉 The firm is on track to retain 90% of its advisors

-- #LynnHouston #MatthewHouston #RossStripling #StevenPhan #JennaVitosh #NataliePaige #RichSteinmeier #EmilyField #Houston #Waltham,Mass. #Lincoln,Neb. #business

Loading quoted post…

Lynn Houston Matthew Houston Ross Stripling Steven Phan Jenna Vitosh Natalie Paige Rich Steinmeier Emily Field

8/27/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqj7zk9dyydgy0j0y0lxad3kryx9ctaasljtzu0r9682sdxn94yjqsahrxzs

LILLY SET FOR STRONG QUARTER AFTER NOVO PROFIT WARNING

https://media.zenfs.com/en/reuters-finance.com/fb0de820f499918f58362d7219c99cca

✍️ Investors expect Eli Lilly to report stronger quarterly sales and profit next week, driven by its leading weight-loss drug Zepbound, which has faced less competition from cheaper copies made by compounding pharmacies.

👉 Eli Lilly expected to report stronger quarterly sales and profit next week 👉 Zepbound leads the U.S. market and has faced less competition from cheaper copies made by compounding pharmacies 👉 Analysts expect Lilly to post second-quarter earnings of $5.57 per share on revenue of $14.71 billion 👉 Lilly's shares fell nearly 5% on Tuesday, reflecting concern about the company's vulnerability

-- #PatrickWingrove #BhanviSatija #DaveWagner #TrungHuynh #EmilyField #BrianMulberry #NewYork #Bengaluru #health

Loading quoted post…

Patrick Wingrove Bhanvi Satija Dave Wagner Trung Huynh Emily Field Brian Mulberry New York Bengaluru

7/31/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqmzae5mnxmqq2zmxry9qq8szec9fkhk0kvewexf060y7jsl425nesknzm0s

NOVO NORDISK SHARES FALL FURTHER AS NEW CEO FACES US CHALLENGES

https://media.zenfs.com/en/reuters-finance.com/71468bdb64d8b7e1238dd50fe1791340

✍️ Novo Nordisk's shares continued to slide as analysts warned of persistent competition from copycat drugs in the US, following a profit warning and the naming of a new CEO.

👉 Novo Nordisk's shares continued to slide after a profit warning and the naming of a new CEO 👉 Analysts warned of persistent competition from copycat drugs in the US 👉 Company's management failed to reassure investors on a call with investors and analysts 👉 Novo Nordisk is intensifying efforts to regain patients taking compounded versions 👉 Company is stepping up dialogue with the US FDA to limit unlawful compounding

-- #MaziarMikeDoustdar #EmilyField #Copenhagen #Denmark #US #business

Loading quoted post…

Maziar Mike Doustdar Emily Field Copenhagen Denmark US business mainstream:perspective

7/30/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq6czp23qzelt8xd2359azj7m7c656d6sm8nfjflavjyaf5uly96pscc657f

NOVO NORDISK FACES 'SHOW ME' MOMENT TO BOOST WEGOVY GROWTH AFTER US COPYCAT BAN

https://media.zenfs.com/en/reuters-finance.com/ce9165e3a9f18cb37fec90deb8859ae2

✍️ Novo Nordisk's weight loss drug Wegovy has seen an increase in prescriptions since a US FDA ban on copycat versions took effect, but the company needs to show robust growth to boost market confidence.

👉 New Wegovy prescriptions have increased by 33% since the FDA ban on compounded versions took effect 👉 Total Wegovy prescriptions have also increased, narrowing the lead for Eli Lilly's Zepbound 👉 Novo Nordisk has rolled out new tactics to bring patients back, including a limited-time discount and better coverage from insurer CVS Health 👉 Analysts are skeptical about the effectiveness of these moves and expect Novo Nordisk to reduce or narrow its full-year guidance ranges

-- #MaggieFick #LarsFruergaardJorgensen #EmilyField #KerryHolford #MarcusMorris-Eyton #LONDON #Copenhagen #Bengalaru #health

Loading quoted post…

Maggie Fick Lars Fruergaard Jorgensen Emily Field Kerry Holford Marcus Morris-Eyton LONDON Copenhagen Bengalaru

7/28/2025

nostr:nevent1qvzqqqqqqypzpw8hnnlkdvh9jwcg5h46vchfmjlnkcnd2efwvxem3nvf2znhxw3cqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq95t7eq54u0ch2pep4zvztvz08fjxcypywx2zlvnazzdd2rmxxeaq24ayuu

REGENERON SHARES SLIDE ON MIXED TRIAL DATA ON SMOKER'S LUNG DRUG

https://media.zenfs.com/en/reuters-finance.com/06ac54dd55eda8b2d3a9858e37b49d31

✍️ Regeneron's experimental drug for smoker's lung failed a late-stage trial, causing its shares to fall 13%.

👉 Regeneron's experimental drug itepekimab failed a late-stage trial for COPD in adult former smokers 👉 The drug showed a significant reduction in exacerbations in the first study, but not in the second 👉 Regeneron's shares fell 13% before the bell on Friday

-- #EmilyField #Bengaluru #health

Loading quoted post…

Emily Field Bengaluru health Technology:perspective

5/30/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqe5c455em6vxuhnd68vjk8jksv92vguygnfqp45u30gdgds0xc3eqvjwh7m

THE LIFE LESSON BEHIND A 335-YEAR-OLD FUNERAL BUSINESS? 'NEVER SLEEP ON AN ARGUMENT'

https://s.yimg.com/ny/api/res/1.2/LdT4ScwB_E8iXEUD4gq1tg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xMDMx/https://s.yimg.com/os/creatr-uploaded-images/2025-05/02a4a620-318d-11f0-9dfd-71a1499a1144

✍️ Jeremy Field, a 10th-generation funeral director, shares his family's 335-year-old business's secrets to success, including reviewing employment contracts and being honest with each other.

👉 CPJ Field is the oldest independent funeral director in the UK, with over 335 years of operation. 👉 The company has conducted over 1 million funerals, including those of Queen Victoria and John Wayne. 👉 CPJ Field is a leader in personalized funeral services, with 35 funeral homes across the south of England. 👉 The company has innovated in the funeral industry, including the use of a glass-sided hearse and funeral management software. 👉 CPJ Field has been subject to hostile takeover bids from US conglomerates and has faced challenges during the pandemic.

-- #JeremyField #EmilyField #CharlesField #ColinField #ThomasLynch #UK #Sussex #Bedfordshire #Buckinghamshire #Brighton #business

Loading quoted post…

Jeremy Field Emily Field Charles Field Colin Field Thomas Lynch UK Sussex Bedfordshire

5/18/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqdzcstajmpd7u9fw62ymgs0sazz80hw3e466zz7var2t9uyfprnws4dv0cn

NOVO NORDISK CEO'S SURPRISE EXIT AFTER SETBACKS IN WEIGHT-LOSS MARKET

https://media.zenfs.com/en/reuters-finance.com/42f872a14221b0a96f54f8153e6dba75

✍️ Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down due to concerns the company is losing its first-mover advantage in the obesity drug market.

👉 Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down 👉 Concerns about losing first-mover advantage in obesity drug market 👉 Analysts and investors have mixed reactions to the news 👉 Company's stock has been weak since mid-2024

-- #LarsFruergaardJorgensen #EmilyField #LukasLeu #KerryHolford #EvanSeigerman #CarstenLonborgMadsen #MikaelBak #EdEgilinsky #SeamusFernandez #HelgeLund #MarkusManns #TrungHuynh #YuriKhodjamirian #London #Copenhagen #business

Loading quoted post…

Lars Fruergaard Jorgensen Emily Field Lukas Leu Kerry Holford Evan Seigerman Carsten Lonborg Madsen Mikael Bak Ed Egilinsky

5/17/2025

nostr:nevent1qvzqqqqqqypzpmcufyygvv773p6xszc6kk3zjnr3zpwgu3ps4w0vne0wex2m22w6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqs96rr49jyelcqunw7jpmg8qer8dx7hkg43sas0jk7dzxsnnqmnrsqpfc5h

WHY AMERICANS PAY SO MUCH MORE FOR PRESCRIPTION DRUGS

https://image.cnbcfm.com/api/v1/image/108145259-1747217764033-gettyimages-2163308489-markets460516_ygl9gaze.jpeg?v=1747217975&w=1920&h=1080

✍️ President Trump signs an executive order to lower prescription drug prices by tying US prices to lower prices abroad, aiming to bring 'fairness to America' and reduce prices by 59% or more.

👉 US pays more for drugs than other countries 👉 Complex reimbursement system and lack of national pricing control contribute to high costs 👉 Drug makers defend higher US costs by citing research and development funding 👉 Trump administration aims to cut out middlemen and facilitate direct sales of drugs at lower prices 👉 Efforts to clampdown on pharmacy benefit managers (PBMs) gaining traction

-- #EmilyField #DonaldTrump #TrungHuynh #NewYorkCity #Europe #health

Loading quoted post…

Emily Field Donald Trump Trung Huynh New York City Europe health mainstream:perspective

5/14/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq3lgeud4k04mf54dsjrku3r9s7387swhgdqas96cj98nvwf3rqphqeazsvv

NOVO NORDISK HOPES TO SEE US WEGOVY SALES RECOVER SOON

https://media.zenfs.com/en/reuters-finance.com/5d667a3e1bd1356650cde50794eafc92

✍️ Novo Nordisk's CEO expects Wegovy weight-loss drug sales to recover in the US once a ban on compound copycats is enforced, despite cutting its 2025 forecasts.

👉 Novo Nordisk's CEO expects Wegovy sales to recover in the US once a ban on compound copycats is enforced. 👉 The company had previously cut its 2025 forecasts due to declining sales. 👉 Wegovy's sales have been impacted by compounding pharmacies producing unauthorized copies of the drug. 👉 The CEO believes that the ban will help the company regain its market share. 👉 Novo Nordisk has launched Wegovy in three new countries, bringing the total to 25 countries.

-- #LarsFruergaardJorgensen #EmilyField #MarkusManns #DonaldTrump #Copenhagen #London #US #Europe #business

Loading quoted post…

Lars Fruergaard Jorgensen Emily Field Markus Manns Donald Trump Copenhagen London US Europe

5/8/2025

nostr:nevent1qvzqqqqqqypzpw8hnnlkdvh9jwcg5h46vchfmjlnkcnd2efwvxem3nvf2znhxw3cqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqwvxw95urj4qu0cgv67ygjpshc3wescctpq6yq8a9f3mdcedevqvqqfpqrf

NOVARTIS TO BUY KIDNEY DISEASE DRUG MAKER REGULUS IN UP TO $1.7 BILLION DEAL

https://media.zenfs.com/en/reuters-finance.com/d56f8afac3da32976a6f4a3850099e04

✍️ Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, gaining access to an experimental drug to treat a life-threatening kidney disease.

👉 Novartis will pay $7 per share in cash upfront and another $7 per share if the lead drug candidate, farabursen, gets regulatory approval. 👉 The deal will give Novartis access to Regulus' proprietary platform to develop treatments targeting microRNAs. 👉 Novartis will gain access to an experimental drug to treat a life-threatening kidney disease.

-- #BhanviSatija #MariamSunny #EmilyField #Bengaluru #health

Loading quoted post…

Bhanvi Satija Mariam Sunny Emily Field Bengaluru health Technology:perspective

4/30/2025

nostr:nevent1qvzqqqqqqypzpmcufyygvv773p6xszc6kk3zjnr3zpwgu3ps4w0vne0wex2m22w6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7npd85nlk027egs9rcg5qgsjjjpp0u67xer0y4f24jymx0reeznsvjpdz4

5 EUROPEAN STOCKS TO WATCH THIS EARNINGS SEASON AS TRUMP'S TARIFFS HIT

https://image.cnbcfm.com/api/v1/image/107428673-1718289865540-gettyimages-2150436953-76036832.jpeg?v=1744895036&w=1920&h=1080

✍️ Investors are entering 2025's first-quarter earnings season with uncertainty due to US President Donald Trump's tariffs, which have exceeded even the most bearish forecasts.

👉 US President Donald Trump's tariffs have created uncertainty and volatility in the global economy. 👉 Several major European companies have already reported negative effects from the tariffs. 👉 The tariffs have exceeded even the most bearish forecasts. 👉 The earnings reports of several major European companies, including Maersk, Shell, Volkswagen, Lufthansa, and Novo Nordisk, may be affected by the tariffs. 👉 A trade war between the US and China could have far-reaching repercussions on the global economy.

-- #DonaldTrump #WaelSawan #ArnoAntlitz #CarstenSpohr #HowardLutnick #EmilyField #UnitedStates #China #Europe #UK #Australia #Tennessee #Chattanooga #business

Loading quoted post…

Donald Trump Wael Sawan Arno Antlitz Carsten Spohr Howard Lutnick Emily Field United States China

4/22/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqq5v2lesn05gsl93melqjljp5frxjduz9tzd6p5ut6fpnzsrskndsdlx9rs

IS ABBVIE INC. (ABBV) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/m1YYSOl9HO_x0LHuYGlC8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee

✍️ The article discusses the trend of US pharmaceutical companies acquiring Chinese pharmaceutical firms for their sophisticated development skills and ability to produce potent compounds at a lower cost.

👉 US pharmaceutical companies are acquiring Chinese pharmaceutical firms for their sophisticated development skills and ability to produce potent compounds at a lower cost. 👉 30% of big pharma acquisitions in 2024 involved Chinese corporations. 👉 Chinese companies can produce potent compounds in large quantities and charge a lower price. 👉 Chinese companies have a more streamlined development process, allowing them to start testing on human subjects more quickly. 👉 AbbVie Inc. (NYSE:ABBV) is one of the best pharma stocks to buy for long-term growth, with a 5-year revenue growth of 10% and a strong dividend growth pattern.

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

4/19/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqdn28chulreum6n37q923dwd7xltpctrd5jm3g7c9xzju6yst85psqc0egc

IS SUPERNUS PHARMACEUTICALS, INC. (SUPN) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/AihkCKu2J2kOl4fxB2W09A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/8c3caeb00dc5c0b78c9240a4c554fc18

✍️ The US pharmaceutical industry is increasingly turning to China for drug deals, with 30% of big pharma acquisitions involving Chinese corporations in 2024, up from 20% the previous year.

👉 30% of big pharma acquisitions in 2024 involved Chinese corporations 👉 Chinese pharmaceutical firms' sophisticated development skills and ability to produce potent compounds in large quantities 👉 Lower pricing of Chinese medications 👉 Shift in industry's business strategy from buying US biotechs to licensing agreements with Chinese companies 👉 Potential implications for American startups and the overall industry

-- #TimOpler #EmilyField #China #US #health

Loading quoted post…

Tim Opler Emily Field China US health mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqa7mjh9laa29u3gjffqdqx602pedr6yuv4as8pn86r03ycuf795fsz3gr5l

IS NOVO NORDISK A/S (NVO) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/Qtw2rnxhgzGJSiq9V2dNrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/8ee01456c2860ad756980e44c064cbb6

✍️ The article discusses the trend of US pharmaceutical companies acquiring medications from Chinese corporations, and how Novo Nordisk A/S (NYSE:NVO) stands out among the best pharma stocks to buy for long-term growth.

👉 US pharmaceutical companies are increasingly acquiring medications from Chinese corporations 👉 30% of big pharma acquisitions in 2024 involved Chinese companies 👉 Chinese pharmaceutical firms are able to produce potent compounds at a lower cost 👉 Novo Nordisk A/S (NYSE:NVO) is a Denmark-based global healthcare company that specializes in chronic disease treatments 👉 The company has achieved impressive financial results in 2024

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqqydt8le2vfffvfv3lc2zrg0r094uvd9u2rz2xzpr09gxzz7kmpnqt6pn5w

IS ASTRAZENECA PLC (AZN) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/ZxTm_Tzoh0.yFsaiRo6CgA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/9424dea817e4dd53df499193fc019daa

✍️ The article discusses the trend of US pharmaceutical companies acquiring drugs from Chinese corporations, citing the latter's sophisticated development skills and lower production costs.

👉 US pharmaceutical companies are acquiring drugs from Chinese corporations 👉 Chinese companies are producing potent compounds in large quantities and charging lower prices 👉 About 30% of big pharma acquisitions in 2024 involved Chinese companies 👉 Experts attribute this trend to Chinese companies' sophisticated development skills 👉 Tariffs may impact the pharmaceutical industry 👉 American startups may be affected by the trend

-- #TimOpler #EmilyField #KenGriffin #China #US #UK #Cambridge #business

Loading quoted post…

Tim Opler Emily Field Ken Griffin China US UK Cambridge business

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqmnqfe2m776takfrehmcs4w6g4yelyvl2kgxsa2jeksvu6j7et6uqe67rf8

IS MERCK & CO., INC. (MRK) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/krpa0cobX2AdeFb7DJ59pg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a

✍️ The article discusses the trend of US pharmaceutical companies acquiring drugs from Chinese corporations, and how this trend may impact the US pharmaceutical industry.

👉 US pharmaceutical companies are increasingly acquiring drugs from Chinese corporations 👉 30% of big pharma acquisitions in 2024 involved Chinese corporations 👉 Chinese companies' sophisticated development skills and ability to produce potent compounds at a lower cost are cited as reasons for this trend 👉 Tariffs may impact the pharmaceutical industry 👉 Obesity medications' performance is still up for debate

-- #TimOpler #EmilyField #AsadHaider #China #US #business

Loading quoted post…

Tim Opler Emily Field Asad Haider China US business mainstream:perspective

4/16/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqwrga00jtnfuuap3lsx9javenqxrgs6ela9dhmfp9ltj949r323fqfe6wm9

IS PACIRA BIOSCIENCES, INC. (PCRX) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/_aOcEqukttWsARV0Fw0NRQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/ac4caa9aa7e79bd6e4c34742e25c3929

✍️ The article discusses the trend of US pharmaceutical companies acquiring medications from Chinese corporations, citing factors such as sophisticated development skills and lower prices.

👉 US pharmaceutical companies are acquiring medications from Chinese corporations 👉 30% of big pharma acquisitions in 2024 involved Chinese corporations 👉 Chinese pharmaceutical firms' sophisticated development skills and lower prices are cited as factors 👉 The trend may impact the US pharmaceutical industry, with some experts predicting it may destroy American startups

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqwjnw8acscmzffjpkwwgx7x956294fnjc3xmeh6sfejj9ggvvuymsdxedmk

IS BRISTOL-MYERS SQUIBB COMPANY (BMY) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/ZsrqNB_sdV78LPtS9DZ12A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036

✍️ The US pharmaceutical industry is shifting its focus to China for drug deals, with 30% of Big Pharma acquisitions involving Chinese corporations in 2024.

👉 30% of Big Pharma acquisitions in 2024 involved Chinese corporations 👉 Chinese pharmaceutical firms' sophisticated development skills and lower production costs 👉 Dearth of venture capital in China 👉 Potential impacts on the US pharmaceutical industry, including the possibility of American startups being destroyed or benefiting from the competition

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq6w65n9fq4z22v2zzr0anskjtpjwspdt6pc276ttug7wkcmw5rg5skgr4s4

IS AMPHASTAR PHARMACEUTICALS, INC. (AMPH) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/8LX0Oqg3BP66eppSFmcY4w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/d5dcc4abc1dca2a68167e760bdf3876d

✍️ The article discusses the trend of US pharmaceutical companies acquiring medications from Chinese corporations, and the implications for the industry.

👉 US pharmaceutical companies are increasingly acquiring medications from Chinese corporations 👉 Chinese pharmaceutical firms have sophisticated development skills and lower production costs 👉 30% of Big Pharma acquisitions involving at least $50 million upfront in 2024 involved Chinese corporations 👉 Tariffs may impact the pharmaceutical industry 👉 Obesity medications have inconsistent results 👉 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) reported net revenues of $191.2 million in the third quarter of 2024

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqm8qr9nhwwfyqvw5tmeesh7cphgw29llzgmfr7zuh68q7tjaejvksw37e74

IS AMNEAL PHARMACEUTICALS, INC. (AMRX) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/l7CXyIBxdgC11UbghQRKAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/34e5f9b043b3d4fdd58d90d8c07a5bc6

✍️ The US pharmaceutical industry is increasingly turning to China for drug deals, with 30% of big pharma acquisitions involving Chinese corporations in 2024. This trend is expected to continue, with experts citing the sophistication of Chinese pharmaceutical firms and their ability to produce potent compounds at a lower cost.

👉 The US pharmaceutical industry is increasingly turning to China for drug deals 👉 30% of big pharma acquisitions involving Chinese corporations in 2024 👉 Chinese pharmaceutical firms are able to produce potent compounds at a lower cost 👉 Experts believe that this trend is here to stay 👉 The trend is not without its challenges, and could lead to the destruction of American startups

-- #TimOpler #EmilyField #China #US #health

Loading quoted post…

Tim Opler Emily Field China US health mainstream:perspective

nostr:nevent1qvzqqqqqqypzpmcufyygvv773p6xszc6kk3zjnr3zpwgu3ps4w0vne0wex2m22w6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq5vfktanrj4ql6v9yvjzn364q22hy68ksjkywuazqcwfpwk9y82us9fveal

EUROPE'S PHARMA INDUSTRY BRACES FOR TARIFFS AS CARVE-OUT HOPES FADE

https://image.cnbcfm.com/api/v1/image/108044272-1728325596986-FAKE-WEGOVY-JFK---1.jpg?v=1728325711&w=1920&h=1080

✍️ The pharmaceutical industry in Europe is bracing for the potential impact of US tariffs, as hopes of an industry-wide exemption fade.

👉 Europharmaceutical sector bracing for potential impact of US tariffs 👉 Industry lobbying for phased approach to duties on imports to the US 👉 Companies may relocate manufacturing stateside to avoid tariffs 👉 Lack of clarity causing negative secondary effects

-- #EsterBaiget #HelgeLund #EmilyField #MortenBødskov #Denmark #JFKAirport #US #business

Loading quoted post…

Ester Baiget Helge Lund Emily Field Morten Bødskov Denmark JFK Airport US business

4/2/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq5w3m4s54evsje4cf9en89adf9jj0chnraey3a9euwjycqpzvgrvqvsdjem

NOVO NORDISK’S WORST MONTH SINCE 2002 HIGHLIGHTS GROWTH CONCERNS

https://media.zenfs.com/en/bloomberg_markets_842/ec54e7514a11ba20314f8dcfd79e9472

✍️ Novo Nordisk A/S shares have fallen 28% in March, their worst month in over two decades, as investors scrutinize weekly US prescription data for signs of growth for its obesity drug Wegovy.

👉 Novo Nordisk A/S shares have fallen 28% in March, their worst month in over two decades. 👉 Investors are scrutinizing weekly US prescription data for signs of growth for its obesity drug Wegovy. 👉 Disappointing data from a mid-stage trial for its weight-loss pill monlunabant and weaker-than-anticipated results for its experimental shot CagriSema have hit the company's shares. 👉 Analysts are questioning the company's pre-eminent growth story. 👉 Most analysts remain optimistic, with 24 of 34 firms tracked by Bloomberg rating Novo shares 'buy'.

-- #ThibaultBoutherin #LuyiGuo #EmilyField #SachinJain #DavidEvans #business

Loading quoted post…

Thibault Boutherin Luyi Guo Emily Field Sachin Jain David Evans business mainstream:perspective

3/31/2025

nostr:nevent1qvzqqqqqqypzpw8hnnlkdvh9jwcg5h46vchfmjlnkcnd2efwvxem3nvf2znhxw3cqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqnywmgh2n4s5d43pjhqql37xh8la63asrankjy7r2nrxn69z6x46q2xm5yg

INVESTORS SEEK ANSWERS ON NOVO NORDISK'S NEXT-GEN OBESITY DRUG CAGRISEMA

https://media.zenfs.com/en/reuters-finance.com/c7954da1c3a9f8499e1984e1cb085f22

✍️ Novo Nordisk is under pressure from investors to provide more information about its next-generation obesity drug candidate CagriSema, amid concerns over trial results and potential side-effects.

👉 Novo Nordisk's CagriSema is a next-generation obesity drug candidate 👉 Patients in the trial reported significant side-effects, including nausea, constipation, and fatigue 👉 Investors are concerned about the drug's efficacy and tolerability 👉 Novo Nordisk is under pressure to provide more information about the trial results and dosing regimen

-- #Jane #MichelleRivera #Leigh #LukasLeu #EmilyField #LONDON #SANFRANCISCO #Dallas,Texas #Switzerland #health

Loading quoted post…

Jane Michelle Rivera Leigh Lukas Leu Emily Field LONDON SAN FRANCISCO Dallas, Texas

2/4/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvja8j7h53md2xyychxac3qlm9p09nzlwxa8qek07dwp2k07zwfesj8mnmv

WHY 2025 WILL BE AN INFLECTION FOR NOVO NORDISK, ELI LILLY'S GLP-1S

https://s.yimg.com/ny/api/res/1.2/iJ6s2L2SKsc8kUjU4G2Q3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2025-01/2ef84540-cc4f-11ef-b7d3-e4f72e0784fb

✍️ Barclays head of European pharmaceuticals research, Emily Field, discusses her outlook for the GLP-1 market in 2025, expecting revenue upside and benefits from capacity expansion.

👉 Emily Field discusses her outlook for the GLP-1 market in 2025 👉 Both Novo Nordisk and Eli Lilly have clinical catalysts scheduled throughout the year 👉 Prescription data is expected to drive revenue upside and impact the sector 👉 Both companies have invested billions in capacity expansion 👉 Capacity expansion is expected to start showing benefits in 2025

-- #EmilyField #SeanaSmith #BradSmith #NaomiBuchanan #business

Loading quoted post…

Emily Field Seana Smith Brad Smith Naomi Buchanan business mainstream:perspective

1/6/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqeydw0heds6hr84pj2mvh9gmlu3msl3xc7qkpjc24vfn502m9f4ustq8rzr

ASTRAZENECA’S CHINA-FUELED PLUNGE MAY BE DIFFICULT TO SHAKE OFF

https://media.zenfs.com/en/bloomberg_markets_842/14c746aa30c0ba939a3676df1ae61126

✍️ AstraZeneca's stock plummeted over 25% after a market valuation of £171 billion to £150 billion due to a deepening investigation into its China unit by Chinese authorities.

👉 AstraZeneca's stock plummeted over 25% due to a deepening investigation into its China unit by Chinese authorities. 👉 The company's CEO, Pascal Soriot, is facing the challenge of handling the fallout from the investigation. 👉 The investigation is probing alleged illegal importation of cancer drugs and data privacy breaches. 👉 The company's stock has been under pressure since September. 👉 Analysts are predicting a drawn-out process for the company to resolve the issue.

-- #PascalSoriot #NareshChouhan #LeonWang #AradhanaSarin #EmilyField #MatthewWeston #RajanSharma #MartinWalker #SteveScala #SeanConroy #China #HongKong #UK #mainstream #business

Loading quoted post…

Pascal Soriot Naresh Chouhan Leon Wang Aradhana Sarin Emily Field Matthew Weston Rajan Sharma Martin Walker

11/9/2024

Layer3.news

AI by layer3.news

Filtering by: Emily Field · clear filter

nostr:nevent1qvzqqqqqqypzpmcufyygvv773p6xszc6kk3zjnr3zpwgu3ps4w0vne0wex2m22w6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqaw8u6etl8anlwejawsheha0ch7ewefapvc8gagdlw46wzpfc2emqct2lm3

WHY MEDICARE PRICE NEGOTIATIONS MATTER FOR NOVO NORDISK, ASTRAZENECA, AND OTHER EUROPEAN PHARMA COMPANIES

https://image.cnbcfm.com/api/v1/image/108226743-1763385742494-gettyimages-2212016375-NOVO_WEGOVY.jpeg?v=1763385821&w=1920&h=1080

✍️ The article discusses the impact of the Inflation Reduction Act on drug pricing in the US, with the Centers for Medicare & Medicaid Services (CMS) negotiating prices for 15 blockbuster drugs, resulting in discounts ranging from 38% to 85%

-- #DonaldTrump #ChrisKlomp #EmilyField #US #Europe #health

Loading quoted post…

Donald Trump Chris Klomp Emily Field US Europe health mainstream:perspective

11/26/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqqypukfw5y7he3mzvs4jfkdade8nhvcm2nzan44hrnxn22d86lecqp0g8t3

LPL ATTRACTS $700M TEXAS TEAM FROM WEDBUSH SECURITIES

https://media.zenfs.com/en/wealth_management_474/d904e9fba01357a0561d2f85c63f3a62

✍️ A Houston-based team, Skyward Financial, managing $700 million in client assets, joins LPL Financial from Wedbush Securities, citing the need for better technology and scalability.

-- #LynnHouston #MatthewHouston #RossStripling #StevenPhan #JennaVitosh #NataliePaige #RichSteinmeier #EmilyField #Houston #Waltham,Mass. #Lincoln,Neb. #business

Loading quoted post…

Lynn Houston Matthew Houston Ross Stripling Steven Phan Jenna Vitosh Natalie Paige Rich Steinmeier Emily Field

8/27/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqj7zk9dyydgy0j0y0lxad3kryx9ctaasljtzu0r9682sdxn94yjqsahrxzs

LILLY SET FOR STRONG QUARTER AFTER NOVO PROFIT WARNING

https://media.zenfs.com/en/reuters-finance.com/fb0de820f499918f58362d7219c99cca

✍️ Investors expect Eli Lilly to report stronger quarterly sales and profit next week, driven by its leading weight-loss drug Zepbound, which has faced less competition from cheaper copies made by compounding pharmacies.

-- #PatrickWingrove #BhanviSatija #DaveWagner #TrungHuynh #EmilyField #BrianMulberry #NewYork #Bengaluru #health

Loading quoted post…

Patrick Wingrove Bhanvi Satija Dave Wagner Trung Huynh Emily Field Brian Mulberry New York Bengaluru

7/31/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqmzae5mnxmqq2zmxry9qq8szec9fkhk0kvewexf060y7jsl425nesknzm0s

NOVO NORDISK SHARES FALL FURTHER AS NEW CEO FACES US CHALLENGES

https://media.zenfs.com/en/reuters-finance.com/71468bdb64d8b7e1238dd50fe1791340

✍️ Novo Nordisk's shares continued to slide as analysts warned of persistent competition from copycat drugs in the US, following a profit warning and the naming of a new CEO.

-- #MaziarMikeDoustdar #EmilyField #Copenhagen #Denmark #US #business

Loading quoted post…

Maziar Mike Doustdar Emily Field Copenhagen Denmark US business mainstream:perspective

7/30/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq6czp23qzelt8xd2359azj7m7c656d6sm8nfjflavjyaf5uly96pscc657f

NOVO NORDISK FACES 'SHOW ME' MOMENT TO BOOST WEGOVY GROWTH AFTER US COPYCAT BAN

https://media.zenfs.com/en/reuters-finance.com/ce9165e3a9f18cb37fec90deb8859ae2

✍️ Novo Nordisk's weight loss drug Wegovy has seen an increase in prescriptions since a US FDA ban on copycat versions took effect, but the company needs to show robust growth to boost market confidence.

-- #MaggieFick #LarsFruergaardJorgensen #EmilyField #KerryHolford #MarcusMorris-Eyton #LONDON #Copenhagen #Bengalaru #health

Loading quoted post…

Maggie Fick Lars Fruergaard Jorgensen Emily Field Kerry Holford Marcus Morris-Eyton LONDON Copenhagen Bengalaru

7/28/2025

nostr:nevent1qvzqqqqqqypzpw8hnnlkdvh9jwcg5h46vchfmjlnkcnd2efwvxem3nvf2znhxw3cqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq95t7eq54u0ch2pep4zvztvz08fjxcypywx2zlvnazzdd2rmxxeaq24ayuu

REGENERON SHARES SLIDE ON MIXED TRIAL DATA ON SMOKER'S LUNG DRUG

https://media.zenfs.com/en/reuters-finance.com/06ac54dd55eda8b2d3a9858e37b49d31

✍️ Regeneron's experimental drug for smoker's lung failed a late-stage trial, causing its shares to fall 13%.

-- #EmilyField #Bengaluru #health

Loading quoted post…

Emily Field Bengaluru health Technology:perspective

5/30/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqe5c455em6vxuhnd68vjk8jksv92vguygnfqp45u30gdgds0xc3eqvjwh7m

THE LIFE LESSON BEHIND A 335-YEAR-OLD FUNERAL BUSINESS? 'NEVER SLEEP ON AN ARGUMENT'

https://s.yimg.com/ny/api/res/1.2/LdT4ScwB_E8iXEUD4gq1tg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xMDMx/https://s.yimg.com/os/creatr-uploaded-images/2025-05/02a4a620-318d-11f0-9dfd-71a1499a1144

✍️ Jeremy Field, a 10th-generation funeral director, shares his family's 335-year-old business's secrets to success, including reviewing employment contracts and being honest with each other.

-- #JeremyField #EmilyField #CharlesField #ColinField #ThomasLynch #UK #Sussex #Bedfordshire #Buckinghamshire #Brighton #business

Loading quoted post…

Jeremy Field Emily Field Charles Field Colin Field Thomas Lynch UK Sussex Bedfordshire

5/18/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqdzcstajmpd7u9fw62ymgs0sazz80hw3e466zz7var2t9uyfprnws4dv0cn

NOVO NORDISK CEO'S SURPRISE EXIT AFTER SETBACKS IN WEIGHT-LOSS MARKET

https://media.zenfs.com/en/reuters-finance.com/42f872a14221b0a96f54f8153e6dba75

✍️ Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down due to concerns the company is losing its first-mover advantage in the obesity drug market.

-- #LarsFruergaardJorgensen #EmilyField #LukasLeu #KerryHolford #EvanSeigerman #CarstenLonborgMadsen #MikaelBak #EdEgilinsky #SeamusFernandez #HelgeLund #MarkusManns #TrungHuynh #YuriKhodjamirian #London #Copenhagen #business

Loading quoted post…

Lars Fruergaard Jorgensen Emily Field Lukas Leu Kerry Holford Evan Seigerman Carsten Lonborg Madsen Mikael Bak Ed Egilinsky

5/17/2025

nostr:nevent1qvzqqqqqqypzpmcufyygvv773p6xszc6kk3zjnr3zpwgu3ps4w0vne0wex2m22w6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqs96rr49jyelcqunw7jpmg8qer8dx7hkg43sas0jk7dzxsnnqmnrsqpfc5h

WHY AMERICANS PAY SO MUCH MORE FOR PRESCRIPTION DRUGS

https://image.cnbcfm.com/api/v1/image/108145259-1747217764033-gettyimages-2163308489-markets460516_ygl9gaze.jpeg?v=1747217975&w=1920&h=1080

✍️ President Trump signs an executive order to lower prescription drug prices by tying US prices to lower prices abroad, aiming to bring 'fairness to America' and reduce prices by 59% or more.

-- #EmilyField #DonaldTrump #TrungHuynh #NewYorkCity #Europe #health

Loading quoted post…

Emily Field Donald Trump Trung Huynh New York City Europe health mainstream:perspective

5/14/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq3lgeud4k04mf54dsjrku3r9s7387swhgdqas96cj98nvwf3rqphqeazsvv

NOVO NORDISK HOPES TO SEE US WEGOVY SALES RECOVER SOON

https://media.zenfs.com/en/reuters-finance.com/5d667a3e1bd1356650cde50794eafc92

✍️ Novo Nordisk's CEO expects Wegovy weight-loss drug sales to recover in the US once a ban on compound copycats is enforced, despite cutting its 2025 forecasts.

-- #LarsFruergaardJorgensen #EmilyField #MarkusManns #DonaldTrump #Copenhagen #London #US #Europe #business

Loading quoted post…

Lars Fruergaard Jorgensen Emily Field Markus Manns Donald Trump Copenhagen London US Europe

5/8/2025

nostr:nevent1qvzqqqqqqypzpw8hnnlkdvh9jwcg5h46vchfmjlnkcnd2efwvxem3nvf2znhxw3cqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqwvxw95urj4qu0cgv67ygjpshc3wescctpq6yq8a9f3mdcedevqvqqfpqrf

NOVARTIS TO BUY KIDNEY DISEASE DRUG MAKER REGULUS IN UP TO $1.7 BILLION DEAL

https://media.zenfs.com/en/reuters-finance.com/d56f8afac3da32976a6f4a3850099e04

✍️ Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, gaining access to an experimental drug to treat a life-threatening kidney disease.

-- #BhanviSatija #MariamSunny #EmilyField #Bengaluru #health

Loading quoted post…

Bhanvi Satija Mariam Sunny Emily Field Bengaluru health Technology:perspective

4/30/2025

nostr:nevent1qvzqqqqqqypzpmcufyygvv773p6xszc6kk3zjnr3zpwgu3ps4w0vne0wex2m22w6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7npd85nlk027egs9rcg5qgsjjjpp0u67xer0y4f24jymx0reeznsvjpdz4

5 EUROPEAN STOCKS TO WATCH THIS EARNINGS SEASON AS TRUMP'S TARIFFS HIT

https://image.cnbcfm.com/api/v1/image/107428673-1718289865540-gettyimages-2150436953-76036832.jpeg?v=1744895036&w=1920&h=1080

✍️ Investors are entering 2025's first-quarter earnings season with uncertainty due to US President Donald Trump's tariffs, which have exceeded even the most bearish forecasts.

-- #DonaldTrump #WaelSawan #ArnoAntlitz #CarstenSpohr #HowardLutnick #EmilyField #UnitedStates #China #Europe #UK #Australia #Tennessee #Chattanooga #business

Loading quoted post…

Donald Trump Wael Sawan Arno Antlitz Carsten Spohr Howard Lutnick Emily Field United States China

4/22/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqq5v2lesn05gsl93melqjljp5frxjduz9tzd6p5ut6fpnzsrskndsdlx9rs

IS ABBVIE INC. (ABBV) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/m1YYSOl9HO_x0LHuYGlC8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee

✍️ The article discusses the trend of US pharmaceutical companies acquiring Chinese pharmaceutical firms for their sophisticated development skills and ability to produce potent compounds at a lower cost.

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

4/19/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqdn28chulreum6n37q923dwd7xltpctrd5jm3g7c9xzju6yst85psqc0egc

IS SUPERNUS PHARMACEUTICALS, INC. (SUPN) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/AihkCKu2J2kOl4fxB2W09A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/8c3caeb00dc5c0b78c9240a4c554fc18

✍️ The US pharmaceutical industry is increasingly turning to China for drug deals, with 30% of big pharma acquisitions involving Chinese corporations in 2024, up from 20% the previous year.

-- #TimOpler #EmilyField #China #US #health

Loading quoted post…

Tim Opler Emily Field China US health mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqa7mjh9laa29u3gjffqdqx602pedr6yuv4as8pn86r03ycuf795fsz3gr5l

IS NOVO NORDISK A/S (NVO) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/Qtw2rnxhgzGJSiq9V2dNrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/8ee01456c2860ad756980e44c064cbb6

✍️ The article discusses the trend of US pharmaceutical companies acquiring medications from Chinese corporations, and how Novo Nordisk A/S (NYSE:NVO) stands out among the best pharma stocks to buy for long-term growth.

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqqydt8le2vfffvfv3lc2zrg0r094uvd9u2rz2xzpr09gxzz7kmpnqt6pn5w

IS ASTRAZENECA PLC (AZN) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/ZxTm_Tzoh0.yFsaiRo6CgA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/9424dea817e4dd53df499193fc019daa

✍️ The article discusses the trend of US pharmaceutical companies acquiring drugs from Chinese corporations, citing the latter's sophisticated development skills and lower production costs.

-- #TimOpler #EmilyField #KenGriffin #China #US #UK #Cambridge #business

Loading quoted post…

Tim Opler Emily Field Ken Griffin China US UK Cambridge business

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqmnqfe2m776takfrehmcs4w6g4yelyvl2kgxsa2jeksvu6j7et6uqe67rf8

IS MERCK & CO., INC. (MRK) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/krpa0cobX2AdeFb7DJ59pg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a

✍️ The article discusses the trend of US pharmaceutical companies acquiring drugs from Chinese corporations, and how this trend may impact the US pharmaceutical industry.

-- #TimOpler #EmilyField #AsadHaider #China #US #business

Loading quoted post…

Tim Opler Emily Field Asad Haider China US business mainstream:perspective

4/16/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqwrga00jtnfuuap3lsx9javenqxrgs6ela9dhmfp9ltj949r323fqfe6wm9

IS PACIRA BIOSCIENCES, INC. (PCRX) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/_aOcEqukttWsARV0Fw0NRQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/ac4caa9aa7e79bd6e4c34742e25c3929

✍️ The article discusses the trend of US pharmaceutical companies acquiring medications from Chinese corporations, citing factors such as sophisticated development skills and lower prices.

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqwjnw8acscmzffjpkwwgx7x956294fnjc3xmeh6sfejj9ggvvuymsdxedmk

IS BRISTOL-MYERS SQUIBB COMPANY (BMY) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/ZsrqNB_sdV78LPtS9DZ12A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036

✍️ The US pharmaceutical industry is shifting its focus to China for drug deals, with 30% of Big Pharma acquisitions involving Chinese corporations in 2024.

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq6w65n9fq4z22v2zzr0anskjtpjwspdt6pc276ttug7wkcmw5rg5skgr4s4

IS AMPHASTAR PHARMACEUTICALS, INC. (AMPH) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/8LX0Oqg3BP66eppSFmcY4w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/d5dcc4abc1dca2a68167e760bdf3876d

✍️ The article discusses the trend of US pharmaceutical companies acquiring medications from Chinese corporations, and the implications for the industry.

-- #TimOpler #EmilyField #China #US #business

Loading quoted post…

Tim Opler Emily Field China US business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqm8qr9nhwwfyqvw5tmeesh7cphgw29llzgmfr7zuh68q7tjaejvksw37e74

IS AMNEAL PHARMACEUTICALS, INC. (AMRX) THE BEST PHARMA STOCK TO BUY FOR LONG TERM GROWTH?

https://s.yimg.com/ny/api/res/1.2/l7CXyIBxdgC11UbghQRKAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/34e5f9b043b3d4fdd58d90d8c07a5bc6

✍️ The US pharmaceutical industry is increasingly turning to China for drug deals, with 30% of big pharma acquisitions involving Chinese corporations in 2024. This trend is expected to continue, with experts citing the sophistication of Chinese pharmaceutical firms and their ability to produce potent compounds at a lower cost.

-- #TimOpler #EmilyField #China #US #health

Loading quoted post…

Tim Opler Emily Field China US health mainstream:perspective

nostr:nevent1qvzqqqqqqypzpmcufyygvv773p6xszc6kk3zjnr3zpwgu3ps4w0vne0wex2m22w6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq5vfktanrj4ql6v9yvjzn364q22hy68ksjkywuazqcwfpwk9y82us9fveal

EUROPE'S PHARMA INDUSTRY BRACES FOR TARIFFS AS CARVE-OUT HOPES FADE

https://image.cnbcfm.com/api/v1/image/108044272-1728325596986-FAKE-WEGOVY-JFK---1.jpg?v=1728325711&w=1920&h=1080

✍️ The pharmaceutical industry in Europe is bracing for the potential impact of US tariffs, as hopes of an industry-wide exemption fade.

-- #EsterBaiget #HelgeLund #EmilyField #MortenBødskov #Denmark #JFKAirport #US #business

Loading quoted post…

Ester Baiget Helge Lund Emily Field Morten Bødskov Denmark JFK Airport US business

4/2/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq5w3m4s54evsje4cf9en89adf9jj0chnraey3a9euwjycqpzvgrvqvsdjem

NOVO NORDISK’S WORST MONTH SINCE 2002 HIGHLIGHTS GROWTH CONCERNS

https://media.zenfs.com/en/bloomberg_markets_842/ec54e7514a11ba20314f8dcfd79e9472

✍️ Novo Nordisk A/S shares have fallen 28% in March, their worst month in over two decades, as investors scrutinize weekly US prescription data for signs of growth for its obesity drug Wegovy.

-- #ThibaultBoutherin #LuyiGuo #EmilyField #SachinJain #DavidEvans #business

Loading quoted post…

Thibault Boutherin Luyi Guo Emily Field Sachin Jain David Evans business mainstream:perspective

3/31/2025

nostr:nevent1qvzqqqqqqypzpw8hnnlkdvh9jwcg5h46vchfmjlnkcnd2efwvxem3nvf2znhxw3cqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqnywmgh2n4s5d43pjhqql37xh8la63asrankjy7r2nrxn69z6x46q2xm5yg

INVESTORS SEEK ANSWERS ON NOVO NORDISK'S NEXT-GEN OBESITY DRUG CAGRISEMA

https://media.zenfs.com/en/reuters-finance.com/c7954da1c3a9f8499e1984e1cb085f22

✍️ Novo Nordisk is under pressure from investors to provide more information about its next-generation obesity drug candidate CagriSema, amid concerns over trial results and potential side-effects.

-- #Jane #MichelleRivera #Leigh #LukasLeu #EmilyField #LONDON #SANFRANCISCO #Dallas,Texas #Switzerland #health

Loading quoted post…

Jane Michelle Rivera Leigh Lukas Leu Emily Field LONDON SAN FRANCISCO Dallas, Texas

2/4/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvja8j7h53md2xyychxac3qlm9p09nzlwxa8qek07dwp2k07zwfesj8mnmv

WHY 2025 WILL BE AN INFLECTION FOR NOVO NORDISK, ELI LILLY'S GLP-1S

https://s.yimg.com/ny/api/res/1.2/iJ6s2L2SKsc8kUjU4G2Q3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2025-01/2ef84540-cc4f-11ef-b7d3-e4f72e0784fb

✍️ Barclays head of European pharmaceuticals research, Emily Field, discusses her outlook for the GLP-1 market in 2025, expecting revenue upside and benefits from capacity expansion.

-- #EmilyField #SeanaSmith #BradSmith #NaomiBuchanan #business

Loading quoted post…

Emily Field Seana Smith Brad Smith Naomi Buchanan business mainstream:perspective

1/6/2025